XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Gain (Loss)
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings (Accumulated Deficit)
Beginning balance (in shares) at Dec. 31, 2018   61,579          
Beginning Balance at Dec. 31, 2018 $ 301,818 $ 6 $ 315,291 $ (12,908) $ (571)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Receipt of Section 16(b) disgorgement, net of tax effect 3,743   3,743        
Shares issued pursuant to stock awards, net of tax withholdings related to vesting of restricted stock units (in shares)   863          
Shares issued pursuant to stock awards, net of tax withholdings related to vesting of restricted stock units 8,587   8,587        
Stock-based compensation 5,335   5,335        
Equity settled contingent consideration (in shares)   21          
Equity-settled contingent consideration 750   750        
Cumulative translation adjustment (1,011)       (1,011)    
Unrealized gain (loss) on investments, net of tax 702       702    
Net income (loss) 5,914     5,914      
Ending balance (in shares) at Mar. 31, 2019   62,463          
Ending Balance at Mar. 31, 2019 325,838 $ 6 333,706 (6,994) (880)    
Beginning balance (in shares) at Dec. 31, 2018   61,579          
Beginning Balance at Dec. 31, 2018 301,818 $ 6 315,291 (12,908) (571)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative translation adjustment 49            
Unrealized gain (loss) on investments, net of tax 912            
Net income (loss) (3,545)            
Ending balance (in shares) at Sep. 30, 2019   65,047          
Ending Balance at Sep. 30, 2019 386,735 $ 7 402,791 (16,453) 390    
Beginning balance (in shares) at Dec. 31, 2018   61,579          
Beginning Balance at Dec. 31, 2018 301,818 $ 6 315,291 (12,908) (571)    
Ending balance (in shares) at Dec. 31, 2019   65,260          
Ending Balance at Dec. 31, 2019 $ 424,907 $ 7 412,191 14,235 (1,526) $ (609) $ (609)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member            
Beginning balance (in shares) at Mar. 31, 2019   62,463          
Beginning Balance at Mar. 31, 2019 $ 325,838 $ 6 333,706 (6,994) (880)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Shares issued pursuant to stock awards, net of tax withholdings related to vesting of restricted stock units (in shares)   309          
Shares issued pursuant to stock awards, net of tax withholdings related to vesting of restricted stock units (620)   (620)        
Stock-based compensation 8,024   8,024        
Cumulative translation adjustment 1,193       1,193    
Unrealized gain (loss) on investments, net of tax 212       212    
Net income (loss) (3,219)     (3,219)      
Ending balance (in shares) at Jun. 30, 2019   62,772          
Ending Balance at Jun. 30, 2019 331,428 $ 6 341,110 (10,213) 525    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Shares issued pursuant to stock awards, net of tax withholdings related to vesting of restricted stock units (in shares)   370          
Shares issued pursuant to stock awards, net of tax withholdings related to vesting of restricted stock units 3,703   3,703        
Induced conversion on 2023 Notes, net of tax (in shares)   2,190          
Induced conversion on 2023 Notes, net of tax (7,904) $ 1 (7,905)        
Extinguishment of capped calls (in shares)   (285)          
Extinguishment of capped calls            
Stock-based compensation 8,836   8,836        
Equity component of 2024 & 2026 Notes, net of issuance costs and tax 122,822   122,822        
Purchase of capped calls, net of tax (65,775)   (65,775)        
Cumulative translation adjustment (133)       (133)    
Unrealized gain (loss) on investments, net of tax (2)       (2)    
Net income (loss) (6,240)     (6,240)      
Ending balance (in shares) at Sep. 30, 2019   65,047          
Ending Balance at Sep. 30, 2019 386,735 $ 7 402,791 (16,453) 390    
Beginning balance (in shares) at Dec. 31, 2019   65,260          
Beginning Balance at Dec. 31, 2019 424,907 $ 7 412,191 14,235 (1,526) (609) (609)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Shares issued pursuant to stock awards, net of tax withholdings related to vesting of restricted stock units (in shares)   625          
Shares issued pursuant to stock awards, net of tax withholdings related to vesting of restricted stock units 1,655   1,655        
Stock-based compensation 13,664   13,664        
Cumulative translation adjustment 998       998    
Unrealized gain (loss) on investments, net of tax 1,243       1,243    
Net income (loss) (15,473)     (15,473)      
Ending balance (in shares) at Mar. 31, 2020   65,885          
Ending Balance at Mar. 31, 2020 426,385 $ 7 427,510 (1,847) 715    
Beginning balance (in shares) at Dec. 31, 2019   65,260          
Beginning Balance at Dec. 31, 2019 424,907 $ 7 412,191 14,235 (1,526) $ (609) $ (609)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative translation adjustment 361            
Unrealized gain (loss) on investments, net of tax 1,750            
Net income (loss) (46,409)            
Ending balance (in shares) at Sep. 30, 2020   66,543          
Ending Balance at Sep. 30, 2020 $ 435,890 $ 7 468,081 (32,783) 585    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member            
Beginning balance (in shares) at Mar. 31, 2020   65,885          
Beginning Balance at Mar. 31, 2020 $ 426,385 $ 7 427,510 (1,847) 715    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Shares issued pursuant to stock awards, net of tax withholdings related to vesting of restricted stock units (in shares)   259          
Shares issued pursuant to stock awards, net of tax withholdings related to vesting of restricted stock units (967)   (967)        
Stock-based compensation 16,923   16,923        
Cumulative translation adjustment 613       613    
Unrealized gain (loss) on investments, net of tax 1,817       1,817    
Net income (loss) (35,293)     (35,293)      
Ending balance (in shares) at Jun. 30, 2020   66,144          
Ending Balance at Jun. 30, 2020 409,478 $ 7 443,466 (37,140) 3,145    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Shares issued pursuant to stock awards, net of tax withholdings related to vesting of restricted stock units (in shares)   399          
Shares issued pursuant to stock awards, net of tax withholdings related to vesting of restricted stock units 3,919   3,919        
Induced conversion on 2023 Notes, net of tax (1)   (1)        
Stock-based compensation 20,697   20,697        
Cumulative translation adjustment (1,250)       (1,250)    
Unrealized gain (loss) on investments, net of tax (1,310)       (1,310)    
Net income (loss) 4,357     4,357      
Ending balance (in shares) at Sep. 30, 2020   66,543          
Ending Balance at Sep. 30, 2020 $ 435,890 $ 7 $ 468,081 $ (32,783) $ 585